Cart
sales@molnova.com
Zelasudil
CAS No. 2365193-22-0
Zelasudil( —— )
Catalog No. M36300 CAS No. 2365193-22-0
Zelasudil (RXC007) is a Rho-related (ROCK) kinase inhibitor for the study of idiopathic pulmonary fibrosis and inflammation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 489 | Get Quote |
|
| 5MG | 613 | Get Quote |
|
| 10MG | 848 | Get Quote |
|
| 25MG | 1628 | Get Quote |
|
| 50MG | 2742 | Get Quote |
|
| 100MG | 3537 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZelasudil
-
NoteResearch use only, not for human use.
-
Brief DescriptionZelasudil (RXC007) is a Rho-related (ROCK) kinase inhibitor for the study of idiopathic pulmonary fibrosis and inflammation.
-
DescriptionZelasudil is a Rho-associated (ROCK) kinase inhibitor. Zelasudil has a ROCK2 binding affinity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetROCK
-
RecptorROCK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2365193-22-0
-
Formula Weight437.445
-
Molecular FormulaC22H21F2N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (228.60 mM; Ultrasonic )
-
SMILESO=C(NCC(F)F)C=1C=CC(=CC1)C=2N=C(NC3=CC=C4NN=CC4=C3C5CC5)N(N2)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee E, et al. Selective ROCK2 inhibition for treatment of edema and associated conditions: World Intellectual Property Organization, WO2022169946. 2022-08-11.
molnova catalog
related products
-
Cotosudil
Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or neurodegenerative diseases or nerve damage.
-
Verosudil
Verosudil (AR-12286) is a potent ROCK inhibitor (Ki=0.2 nM) that effectively lowers intraocular pressure (IOP) in animal models and human subjects.
-
BDP9066
BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.
